FindTrial
Sign In

Effect of Gynaecological and Breast Cancers on Ovarian Reserve in Reproductive Age Women: A Hospital-Based Cross-sectional Study

Effect of Gynaecological and Breast Cancers on Ovarian Reserve in Reproductive Age Women: A Hospital-Based Cross-sectional Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/05/110708
Enrollment
50
Registered
2026-05-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50-C50- Malignant neoplasms of breast Health Condition 2: C51-C58- Malignant neoplasms of female genital organs

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

AIIMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with newly diagnosed gynecological or breast malignancy prior to any treatment intervention (surgery, chemotherapy, radiotherapy). 18-40 years of age. Willing to participate in the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Serum AMH levels: baseline AMH between newly diagnosed cancerTimepoint: baseline—

Secondary

MeasureTime frame
Basal FSH levels day 2 to 5 AFC measured by TVS ans Inhibin B Diagnostic Accuracy: sensitivity, specificity, & AUC-ROC of AMH for ovarian reserve in cancer patientsTimepoint: baseline—

Countries

India

Contacts

Public ContactShivani Jaiswal

AIIMS Rishikesh

jaya.obg@aiimsrishikesh.edu.in9997310120

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026